ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2705

Aberrant Expression and Function of Human Circulating T Follicular Helper Cells and Its Subsets in IgG4 Related Disease

Yu Chen1, Wen Zhang2, Panpan Zhang3, Yanan Zhu1 and Hongxian Yang3, 1Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China, 2Rheuamtology, Peking Union Medical College Hospital, Beijing, China, 3rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: B cells, functions and interleukins (IL), IgG4 Related Disease, PD-1

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: T Cell Biology and Targets in Autoimmune Disease Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To study the expression and function of T follicular helper cells and its subsets in IgG4-related disease(IgG4-RD).

Methods: Flow cytometry was performed to analyze the expression of Tfh cells and its subsets in untreated IgG4-RD patients(n=46) and healthy controls(n=33). With RT-PCR technique, the mRNA levels of Bcl-6, Blimp-1 and IL-21 from IgG4-RD patients were tested. The immunohistochemeistry and immunofluorescence technique were used to assess the location of IL-21 and Tfh cells in the involved tissues of IgG4-RD patients, respectively. Furthermore, by cells co-culture in vitro, the abilities of cTfh and its subsets to help B cells proliferation, apoptosis, differentiation, and producing IgG4 in IgG4-RD were explored.

Results: The frequencies of (CD4+CXCR5+)T, (CD4+CXCR5+ICOS+)T, (CD4+CXCR5+PD-1+)T, PD-1 in (CD4+CXCR5+ICOS+)T and (CD4+CXCR5+ICOS+PD-1) T in IgG4-RD patients were significantly higher in the perphrial blood and involved tissues of IgG4-RD patients compared with healthy controls, and the expression of these cells in those involved tissues were significantly higher than blood. Especially, the percentages of PD-1 in (CD4+CXCR5+ICOS+) cTfh cells was positively correlated to the serum levels of IgG, IgG4, IgG4/IgG%, the number of organ involved, and (CD19+CD24-CD38hi) B cell subset, which has been proved producing higher IgG4 than other B cells. mRNA Bcl6 in CD4+ T cells of IgG4-RD showed no difference with healthy controls while the mRNA Blimp-1 did. mRNA IL-21 in PBMCs of IgG4-RD was also higher compared with healthy controls, and positively correlated with serum levels of IgG4, IgG, IgG4/IgG%. In the involved tissues of IgG4-RD, both of the Tfh cells and IL-21 showed highly expression, mainly distributed around glandular cells or ectopic GC. Importantly, compared to healthy controls, cTfh cells in IgG4-RD patients could more efficiently facilitate B cells proliferation but inhibit cell apoptosis, and enhanced naive B cells differentiate into S memory B cells and (CD19+CD24-CD38hi) B cells, which resulted in much more IgG4 secretion. Furthermore, it was mainly cTfh1 and cTfh2 were significantly higher in IgG4-RD patients compared with healthy controls, and it was mainly cTfh1 and cTfh17 enhanced the ability of B cells proliferation but inhibited apoptosis, while it was mainly cTfh2, as well as cTfh1 promote B cells differentiate into plasma B cells and producing much more IgG4 antibodies in IgG4-RD.

Conclusion: Tfh cells, especially the expression of PD-1 in (CD4+CXCR5+ICOS+) T, as well as IL-21 play vital roles in the pathgenesis of IgG4-RD. Compared to healthy control, Tfh cells from IgG4-RD patient could more efficiently facilitate B cells proliferation but inhibit cell apoptosis, and promote B cells differentiation into S memory B and (CD19+CD24-CD38hi)B cells, which result in strong immune response and more IgG4 secretion. And it was cTfh2, as well as cTfh1 mainly performing the function.


Disclosure: Y. Chen, None; W. Zhang, None; P. Zhang, None; Y. Zhu, None; H. Yang, None.

To cite this abstract in AMA style:

Chen Y, Zhang W, Zhang P, Zhu Y, Yang H. Aberrant Expression and Function of Human Circulating T Follicular Helper Cells and Its Subsets in IgG4 Related Disease [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/aberrant-expression-and-function-of-human-circulating-t-follicular-helper-cells-and-its-subsets-in-igg4-related-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aberrant-expression-and-function-of-human-circulating-t-follicular-helper-cells-and-its-subsets-in-igg4-related-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology